Javelin Biotech

Javelin Biotech (formerly IHB), a spin out from MIT Translational Center for Tissue Chip Technologies, enables biopharma clients to improve lead optimization & clinical trial design by using Organ-on-Chip tech & computational biology to better predict how drugs will perform in humans. Javelin sells specialty phenotypic testing & analytic services and will sell software modules for drug development. 2yr $3m NIH grant, MassConnect participant